全国服务咨询热线:

18438616290

Products产品中心
首页 > 产品中心 > 生化试剂 > 小分子化合物 > abs47027365Homotaurine 3687-18-1

Homotaurine 3687-18-1

简要描述:Homotaurine 3687-18-1
Because of its similarity in structure to the neurotransmitter gamma-aminobutyric acid (GABA), it has GABAergic effects and may be useful as an anticonvulsant.

  • 产品型号:abs47027365
  • 厂商性质:生产厂家
  • 更新时间:2025-12-09
  • 访  问  量:729

详细介绍

品牌absinCAS3687-18-1
分子式C3H9NO3S纯度>98%
分子量139.17货号abs47027365
规格50mg供货周期现货
主要用途as an anticonvulsant应用领域化工,生物产业,农林牧渔,制药/生物制药,综合

Homotaurine 3687-18-1

产品描述
描述

Because of its similarity in structure to the neurotransmitter gamma-aminobutyric acid (GABA), it has GABAergic effects and may be useful as an anticonvulsant. Homotaurine has also been investigated as a potential treatment for Alzheimer's disease. It binds to soluble amyloid beta and inhibits the formation of neurotoxic aggregates that lead to amyloid plaque deposition in the brain. However, clinical trials failed to show improvement compared to placebo.

纯度
>98%
储存/保存方法
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
基本信息
别名
3-氨基丙烷磺酸; Homotaurine;3-Amino-1-propanesulfonic acid
外观
白色结晶性粉末
可溶性/溶解性
H2O : 20 mg/mL (143.71 mM; Need ultrasonic)

DMSO : 1 mg/mL (7.19 mM; Need ultrasonic)
生物活性
靶点
Amyloid-(beta)
参考文献
参考文献
  • 1. Fariello RG, et al. Neurology, 1982, 32 (3): 241–5.

  • 2. Fariello RG, et al. Neurology, 1982, 32 (3): 241–6.

  • 3. Gauthier, S, et al. The journal of nutrition, health & aging, 2009, 13 (6): 550–7.

  • 4. Gauthier, S, et al. The journal of nutrition, health & aging, 2009, 13 (6): 550–8.

  • 5. Aisen PS, et al. Curr Alzheimer Res, 2007, 4 (4): 473–8.

研究领域
研究领域
CancerCancer Metabolism
Drug DiscoverySmall Molecule DrugLead Compound Discovery
Homotaurine 3687-18-1温馨提示:本产品仅作科研实验使用,不支持临床等研究

产品咨询

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
爱必信(上海)生物科技有限公司
地址:上海市浦东新区新浩路58号申江科创园18栋
邮箱:lanwu@univ-bio.com
传真:
关注我们
欢迎您关注我们的微信公众号了解更多信息:
欢迎您关注我们的微信公众号
了解更多信息